4.7 Article

Convergent Identification and Interrogation of Tumor-Intrinsic Factors that Modulate Cancer Immunity In Vivo

Journal

CELL SYSTEMS
Volume 8, Issue 2, Pages 136-+

Publisher

CELL PRESS
DOI: 10.1016/j.cels.2019.01.004

Keywords

-

Funding

  1. Yale SBI/Genetics Startup Fund, NIH/NCI [1DP2CA238295-01, 1R01CA231112-01, 1U54CA209992-8697, 5P50CA196530-A10805, 4P50CA121974-A08306]
  2. Damon Runyon Dale Frey Award [DFS-13-15]
  3. Melanoma Research Alliance [412806, 16-003524]
  4. St-Baldrick's Foundation [426685]
  5. Breast Cancer Alliance
  6. Cancer Research Institute (CLIP)
  7. AACR [499395, 17-20-01-CHEN]
  8. Mary Kay Foundation [017-81]
  9. The V Foundation [V2017-022]
  10. Ludwig Family Foundation
  11. DoD [W81XWH-17-1-0235]
  12. Sontag Foundation
  13. Chenevert Family Foundation
  14. Yale SPORE in lung cancer [5P50CA196530]
  15. Yale Ph.D. training grant from NIH [T32GM007499]
  16. Yale MSTP training grant from NIH [T32GM007205]
  17. NIH/NCI [1U54CA209992]
  18. Cancer Research Institute Irvington Postdoctoral Fellowship
  19. Cancer Research Institute RJ Anderson Postdoctoral Fellowship
  20. USTC student scholarships

Ask authors/readers for more resources

The genetic makeup of cancer cells directs oncogenesis and influences the tumor microenvironment. In this study, we massively profiled genes that functionally drive tumorigenesis using genome-scale in vivo CRISPR screens in hosts with different levels of immunocompetence. As a convergent hit from these screens, Prkar1a mutant cells are able to robustly outgrow as tumors in fully immunocompetent hosts. Functional interrogation showed that Prkar1a loss greatly altered the transcriptome and proteome involved in inflammatory and immune responses as well as extracellular protein production. Single-cell transcriptomic profiling and flow cytometry analysis mapped the tumor microenvironment of Prkar1a mutant tumors and revealed the transcriptomic alterations in host myeloid cells. Taken together, our data suggest that tumor-intrinsic mutations in Prkar1a lead to drastic alterations in the genetic program of cancer cells, thereby remodeling the tumor microenvironment.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available